Clinical Trials Directory

Trials / Completed

CompletedNCT04193124

Prolonged Vasospasm in Subarachnoid Hemorrhage

Clinical Implication of Prolonged Vasospasm in Subarachnoid Hemorrhage

Status
Completed
Phase
Study type
Observational
Enrollment
109 (actual)
Sponsor
Hospital El Cruce · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The prevalence and clinical implications of prolonged cerebral vasospasm in patients with subarachnoid hemorrhage are unknown.

Detailed description

The prevalence and clinical importance of prolonged cerebral vasospasm (after day 21 of bleeding) in patients with subarachnoid hemorrhage is unknown. Objectives: To determine the prevalence and clinical relevance of prolonged vasospasm in patients with subarachnoid hemorrhage secondary to cerebral aneurysm. A prospective and observational study was conducted. Adult patients with a diagnosis of subarcnoid hemorrhage CT scan or presence of blood in the cerebrospinal fluid were incorporated. Patients with vasospasm were followed daily with transcranial doppler. Those with technical impossibility to perform transcranial and pregnant Doppler were excluded. Day 0 was defined, the day of the last bleeding. Evaluation: 1) It was considered in patients with prolonged vasospasm: whether or not it was associated with clinical manifestation (deterioration of the sensory or new neurological deficit) and 2) the magnitude of the vasospasm (mild, moderate or severe) was measured by transcranial doppler.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTtranscranial doppler.Daily monitoring of transcranial doppler until the disappearance of the intracranial vasosparm

Timeline

Start date
2015-04-01
Primary completion
2019-01-01
Completion
2019-12-01
First posted
2019-12-10
Last updated
2019-12-10

Source: ClinicalTrials.gov record NCT04193124. Inclusion in this directory is not an endorsement.